BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1465-542X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
BRCA promoter methylation in sporadic versus BRCA germline mutation-related breast cancers ; volume:19 ; number:1 ; day:31 ; month:5 ; year:2017 ; pages:1-13 ; date:12.2017
Breast cancer research ; 19, Heft 1 (31.5.2017), 1-13, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Vos, Shoko
- Contributor
-
Moelans, Cathy Beatrice
van Diest, Paul Joannes
SpringerLink (Online service)
- DOI
-
10.1186/s13058-017-0856-z
- URN
-
urn:nbn:de:1111-201706253185
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:32 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Vos, Shoko
- Moelans, Cathy Beatrice
- van Diest, Paul Joannes
- SpringerLink (Online service)
Other Objects (12)
BRCA germline mutation test for all woman with ovarian cancer?
RAD21 overexpression is frequently observed in BRCA-X Prostate Cancers
Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls
BRCA 1 and BRCA 2 tumor suppressors protect against endogenous acetaldehyde toxicity
BRCA-assoziierter Brustkrebs : erblicher Brustkrebs: was Sie über die BRCA Muttaion wissen müssen
Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer
Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer
BRCA Testing in Serbia and Montenegro
Die Patentierung von Krankheitsgenen : dargestellt am Beispiel der Patentierung der Brustkrebsgene BRCA 1 und BRCA 2
BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients
Trends in BRCA testing and socioeconomic deprivation
Emerging strategies in BRCA-positive pancreatic cancer
BRCA germline mutation test for all woman with ovarian cancer?
RAD21 overexpression is frequently observed in BRCA-X Prostate Cancers
Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls
BRCA 1 and BRCA 2 tumor suppressors protect against endogenous acetaldehyde toxicity
BRCA-assoziierter Brustkrebs : erblicher Brustkrebs: was Sie über die BRCA Muttaion wissen müssen
Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer
Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer
BRCA Testing in Serbia and Montenegro
Die Patentierung von Krankheitsgenen : dargestellt am Beispiel der Patentierung der Brustkrebsgene BRCA 1 und BRCA 2
BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients
Trends in BRCA testing and socioeconomic deprivation
Emerging strategies in BRCA-positive pancreatic cancer
BRCA germline mutation test for all woman with ovarian cancer?
RAD21 overexpression is frequently observed in BRCA-X Prostate Cancers
Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls
BRCA 1 and BRCA 2 tumor suppressors protect against endogenous acetaldehyde toxicity
BRCA-assoziierter Brustkrebs : erblicher Brustkrebs: was Sie über die BRCA Muttaion wissen müssen
Germline BRCA, chemotherapy response scores, and survival in the neoadjuvant treatment of ovarian cancer
Survival Benefit of Germline BRCA Mutation is Associated with Residual Disease in Ovarian Cancer
BRCA Testing in Serbia and Montenegro
Die Patentierung von Krankheitsgenen : dargestellt am Beispiel der Patentierung der Brustkrebsgene BRCA 1 und BRCA 2
BRCA mutations: screening for germ-line founder mutations among early-onset Syrian breast cancer patients
Trends in BRCA testing and socioeconomic deprivation